Aims and Scope of Journal of NeuroImmune Pharmacology
The Journal of Neuroimmune Pharmacology is a quarterly peer-reviewed scientific journal covering research on the intersection of immunology, pharmacology, and neuroscience as they relate to each other. The journal occasionally publishes special thematic issues. It was established in 2006 and is published by Springer Science+Business Media on behalf of the Society on NeuroImmune Pharmacology. The editor-in-chief is Howard E. Gendelman (University of Nebraska Medical Center). Less
Key Metrics
CiteScore 

8.9
Eigenfactor 

0.001 - 0.005
H-Index 

83
Impact Factor 

5 - 10
SJR 

Q1Immunology

SNIP 

1.17
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of NeuroImmune Pharmacology
Journal of NeuroImmune Pharmacology Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of NeuroImmune Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of NeuroImmune Pharmacology
CA Inhibitor 1 Treatment Does Not Affect Estrous Cyclicity in Mice.
- 9 May 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Targeting Neuroinflammation in the Piriform Cortex-Amygdala: Enhanced Efficacy of Niosome-Based Sodium Butyrate in Ischemic Stroke.
- 21 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Naringin Reverses Chronic Stress-Induced Cognitive Deficits and Enhances Hippocampal Neuroplasticity in Mice.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Ganoderic Acid a Promotes Functional Recovery After Traumatic Brain Injury By Protecting Blood-brain Barrier Integrity and Modulating Microglial Polarization.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Comparative Effectiveness of Rituximab in Treatment-Naïve vs. Switch Patients with Multiple Sclerosis: A Real-World Retrospective Study.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
CA Inhibitor 1 Treatment Does Not Affect Estrous Cyclicity in Mice.
- 9 May 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Targeting Neuroinflammation in the Piriform Cortex-Amygdala: Enhanced Efficacy of Niosome-Based Sodium Butyrate in Ischemic Stroke.
- 21 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Naringin Reverses Chronic Stress-Induced Cognitive Deficits and Enhances Hippocampal Neuroplasticity in Mice.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Ganoderic Acid a Promotes Functional Recovery After Traumatic Brain Injury By Protecting Blood-brain Barrier Integrity and Modulating Microglial Polarization.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Comparative Effectiveness of Rituximab in Treatment-Naïve vs. Switch Patients with Multiple Sclerosis: A Real-World Retrospective Study.
- 13 Apr 2026
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology